ANN ARBOR STAGE IV NON-HODGKIN LYMPHOMA
Clinical trials for ANN ARBOR STAGE IV NON-HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new ANN ARBOR STAGE IV NON-HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for ANN ARBOR STAGE IV NON-HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for aggressive lymphoma: drug combo shows promise
Disease control OngoingThis study tested a new drug, vorinostat, added to standard treatment (R-CHOP) for people with newly diagnosed advanced-stage diffuse large B-cell lymphoma. The goal was to find the safest dose and see if the combination improves how long patients stay cancer-free. 83 participant…
Matched conditions: ANN ARBOR STAGE IV NON-HODGKIN LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Experimental combo targets tough cancers in early trial
Disease control OngoingThis early-phase study tests a new drug called veliparib combined with two chemotherapy drugs (cyclophosphamide and doxorubicin) in people with advanced solid tumors or non-Hodgkin lymphoma that has spread or can't be removed by surgery. The main goal is to find the safest dose a…
Matched conditions: ANN ARBOR STAGE IV NON-HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Gene-Guided hope: pediatric MATCH trial aims to outsmart tough childhood cancers
Knowledge-focused OngoingThis study screens children and young adults (ages 1–21) with advanced solid tumors, lymphomas, or related disorders that have come back or not responded to standard therapy. Researchers analyze the genetic makeup of each patient's tumor to find specific mutations that can be tar…
Matched conditions: ANN ARBOR STAGE IV NON-HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC